The Enterprise Value as of December 2025 (TTM) for Senhwa Biosciences, Inc. (6492.TWO) is 3.02B

According to Senhwa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.02B. This represents a change of 14.92% compared to the average of 2.63B of the last 4 quarters.

Senhwa Biosciences, Inc. (6492.TWO) Historical Enterprise Value (quarterly & annually)

How has 6492.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Senhwa Biosciences, Inc. over the last ten years is 6.15B. The current 3.02B Enterprise Value has changed 4.81% with respect to the historical average. Over the past ten years (40 quarters), 6492.TWO's Enterprise Value was at its highest in in the September 2021 quarter at 11.02B. The Enterprise Value was at its lowest in in the June 2025 quarter at 2.34B.

Senhwa Biosciences, Inc. (6492.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Senhwa Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Senhwa Biosciences, Inc. (6492.TWO) Average Enterprise Value

How has 6492.TWO Enterprise Value performed in the past?

The current Enterprise Value of Senhwa Biosciences, Inc. (6492.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Senhwa Biosciences, Inc. (6492.TWO) Enterprise Value vs. Peers

How is 6492.TWO’s Enterprise Value compared to its peers?

Senhwa Biosciences, Inc.’s Enterprise Value is less than Formosa Pharmaceuticals, Inc. (3.82B), less than Energenesis Biomedical CO.,LTD. (3.15B), less than Medigen Biotechnology Corp. (4.57B), less than BRIM Biotechnology, Inc. (3.10B), less than AnnJi (4.32B), greater than TWi Biotechnology, Inc. (1.35B), less than UnicoCell Biomed Co., Ltd. (4.72B), less than Orient EuroPharma Co., Ltd. (4.57B), less than Synbio Tech Inc. (4.02B), less than Syngen Biotech Co.,Ltd. (3.32B),

Build a custom stock screener for Senhwa Biosciences, Inc. (6492.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senhwa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senhwa Biosciences, Inc. (6492.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senhwa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.